D. Harrich

D. Harrich, C. Hooker, C.William Hooker, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Target Distinct Phases of Early Reverse Transcription

D. Harrich, W. B. Lott, C. Hooker, 2001, Journal of Virology.

Kunjin Virus Replicon Vaccine Vectors Induce Protective CD8+ T-Cell Immunity

D. Harrich, A. Suhrbier, R. Linedale, 2002, Journal of Virology.

HumanT-Cell Leukemia VirusTypesIandII Exhibit Different DNaseIProtection Patterns

D. Harrich, 1988 .

Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.

R. Gaynor, R. Wall, J. García, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.

D. Harrich, N. Davis-Poynter, P. N. Shaw, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

RNA glycosidase and other agents target Tat to inhibit HIV-1 transcription.

D. Harrich, Hongping Jin, 2018, The Biochemical journal.

Differential GrowthKinetics AreExhibited byHuman Immunodeficiency Virus Type1TAR Mutants

D. Harrich, 1994 .

HIV type 1 inhibition by protein kinase C modulatory compounds.

D. Harrich, A. Suhrbier, J. Gardner, 2006, AIDS research and human retroviruses.

Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection

D. Harrich, A. Suhrbier, Dongsheng Li, 2022, Microbiology spectrum.

Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP‐1 and UBP‐1.

R. Gaynor, J. García, D. Harrich, 1988, The EMBO journal.

SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication*

D. Harrich, A. Suhrbier, R. Medcalf, 2006, Journal of Biological Chemistry.

Absolute dependence on kappa B responsive elements for initiation and Tat‐mediated amplification of HIV transcription in blood CD4 T lymphocytes.

R. Gaynor, T. Laín de Lera, D. Harrich, 1995, The EMBO journal.

The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus

D. Harrich, Dongsheng Li, Zhong-lan Wu, 2020, Reviews in medical virology.

An Appetite for Destruction: Detecting Prey-Selective Binding of α-Neurotoxins in the Venom of Afro-Asian Elapids

D. Harrich, Richard J. Harris, B. Fry, 2020, Toxins.

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

D. Harrich, D. Jans, K. Wagstaff, 2012, The Biochemical journal.

Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity

D. Harrich, M. Hussain, Dongsheng Li, 2021, Communications Biology.

Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription

R. Gaynor, D. Harrich, E. Parry, 1999, Journal of Virology.

Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1

S. Kliewer, R. Gaynor, D. Harrich, 1990, Journal of virology.

Tat is required for efficient HIV‐1 reverse transcription

R. Gaynor, D. Harrich, L. F. Garcı́a-Martı́nez, 1997, The EMBO journal.

A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription

R. Gaynor, D. Harrich, C. Ulich, 1996, Journal of virology.

Mechanistic aspects of HIV‐1 reverse transcription initiation

D. Harrich, Bill Hooker, 2002, Reviews in medical virology.

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

D Harrich, R. Gaynor, D. Harrich, 1995, Journal of virology.

Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription

D. Harrich, L. Meredith, D. Warrilow, 2009, Viruses.

Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant

D. Harrich, Dongsheng Li, Yifan Sun, 2019, mBio.

A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes

D. Harrich, M. Lor, Min-Hsuan Lin, 2017, Virology Journal.

Gag-Pol Supplied in trans Is Efficiently Packaged and Supports Viral Function in Human Immunodeficiency Virus Type 1

D. Harrich, J. Mak, M. Hill, 2001, Journal of Virology.

Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription

D. Harrich, N. McMillan, L. Endo-Munoz, 2005, Virology Journal.

Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants

R. Gaynor, D. Harrich, C. Hsu, 1994, Journal of virology.

The Human Immunodeficiency Virus Type 1 TAR RNA Upper Stem-Loop Plays Distinct Roles in Reverse Transcription and RNA Packaging

D. Harrich, E. Parry, C. Hooker, 2000, Journal of Virology.

Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication

R. Gaynor, D. Harrich, G. Mavankal, 1995, Journal of virology.

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

D. Harrich, A. Suhrbier, J. Mackenzie, 2003, Journal of Virology.

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6

D. Harrich, Ann Apolloni, Ting Wei, 2013, Virology Journal.

Human Immunodeficiency Virus Type 1 Protease Regulation of Tat Activity Is Essential for Efficient Reverse Transcription and Replication

D. Harrich, Ann Apolloni, J. Mak, 2003, Journal of Virology.

and David Transcription and Replication Essential for Efficient Reverse Protease Regulation of Tat Activity Is Human Immunodeficiency Virus Type

D. Harrich, Ann Apolloni, J. Mak, 2003 .

Human immunodeficiency virus type 1 reverse transcription is stimulated by tat from other lentiviruses.

D. Harrich, Ann Apolloni, J. Scott, 2002, Virology.

HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain

D. Harrich, D. Soares, Dongsheng Li, 2018, mBio.

Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity

D. Harrich, M. Hussain, Dongsheng Li, 2021, Communications Biology.

TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.

R. Gaynor, J. García, D. Harrich, 1990, The EMBO journal.

Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort

M. Gill, N. Saksena, D. Harrich, 2007, Virology Journal.

Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat

D Harrich, R. Gaynor, D. Harrich, 1989, Journal of virology.

Nullbasic, a Potent Anti-HIV Tat Mutant, Induces CRM1-Dependent Disruption of HIV Rev Trafficking

D. Harrich, Ann Apolloni, D. Jans, 2012, PloS one.

Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns

R. Altman, R. Gaynor, J. García, 1988, Journal of virology.

Strand Transfer and Elongation of HIV-1 Reverse Transcription Is Facilitated by Cell Factors In Vitro

D. Harrich, D. Warrilow, Kylie Warren, 2010, PloS one.

Maturation of the HIV reverse transcription complex: putting the jigsaw together

D. Harrich, G. Tachedjian, D. Warrilow, 2009, Reviews in medical virology.

Toward the “unravelling” of HIV: Host cell factors involved in HIV-1 core uncoating

D. Harrich, D. Rawle, 2018, PLoS pathogens.

Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target

D. Harrich, D. Soares, C. Abbott, 2015, PLoS pathogens.

Binding of the eukaryotic translation elongation factor 1A with the 5’UTR of HIV-1 genomic RNA is important for reverse transcription

D. Harrich, K. Spann, Ting Wei, 2015, Virology Journal.

Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro

D. Harrich, C. Burrell, L. Meredith, 2007, Journal of Virology.

Protein methylation is required to maintain optimal HIV-1 infectivity

David Warrilow, D. Harrich, Ann Apolloni, 2006, Retrovirology.

Human immunodeficiency virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells

D. Harrich, C. Bagley, C. Burrell, 2008 .

The HIV-1 Tat protein stimulates reverse transcription in vitro.

D. Harrich, A. Suhrbier, Ann Apolloni, 2007, Current HIV research.

A Mutant Tat Protein Inhibits HIV-1 Reverse Transcription by Targeting the Reverse Transcription Complex

D. Harrich, Ann Apolloni, Sally Martin, 2015, Journal of Virology.

Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes

D. Harrich, Richard J. Harris, B. Fry, 2020, Neurotoxicity Research.

Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins

R. Gaynor, D. Harrich, P. Estes, 1996, Journal of virology.

HIV-1 Tat implicated as a key factor in viral spread

D. Harrich, Ann Apolloni, D. Warrilow, 2008 .

A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes

D. Harrich, M. Lor, Min-Hsuan Lin, 2017, Virology Journal.

Correction: A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly

Y. Kawaoka, D. Harrich, Takeshi Noda, 2015, PloS one.

A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1

D. Harrich, K. Spann, F. Meunier, 2014, Retrovirology.

Will diverse Tat interactions lead to novel antiretroviral drug targets?

D. Harrich, Ann Apolloni, N. McMillan, 2006, Current drug targets.

Absolute dependence on KB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD 4 T lymphocytes

R. Gaynor, D. Harrich, R. Hay, 2022 .

Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication

D. Fairlie, D. Harrich, Jonathan M. Harris, 2019, Journal of Virology.

Functional domains required for tat‐induced transcriptional activation of the HIV‐1 long terminal repeat.

R. Gaynor, J. García, D. Harrich, 1988, The EMBO journal.

Binding of the eukaryotic translation elongation factor 1A with the 5’UTR of HIV-1 genomic RNA is important for reverse transcription

D. Harrich, K. Spann, Ting Wei, 2015, Virology Journal.

Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells

D. Harrich, Dongsheng Li, M. Lor, 2018, Virologica Sinica.

A U5 repressor of reverse transcription is required for optimal HIV-1 infectivity and replication

C. Isel, D. Harrich, R. Marquet, 2009, Retrovirology.

Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission.

D. Harrich, P. N. Shaw, N. Dang, 2014, Journal of pharmaceutical sciences.

The eukaryotic translation elongation factor 1A regulation of actin stress fibers is important for infectious RSV production

D. Harrich, K. Spann, Ting Wei, 2018, Virology Journal.

SOCS1: a host factor required for HIV-1 Gag trafficking

D. Harrich, H. Sivakumaran, 2008 .

Low back pain and osteoarthritis pain: a perspective of estrogen

D. Harrich, Sidong Yang, D. Klyne, 2023, Bone research.

PUBLISHED VERSION

D. Harrich, C. Bagley, C. Burrell, 2015 .

Human Immunodeficiency Virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells

D. Harrich, C. Bagley, J. Powell, 2008, Retrovirology.

Revisiting transdominant-negative proteins in HIV gene therapy

D. Harrich, Vincent Cutillas, H. Sivakumaran, 2013 .

HIV-1 replication from after cell entry to the nuclear periphery.

D. Harrich, D. Warrilow, 2007, Current HIV research.

Recombinant rabbit single‐chain antibodies bind to the catalytic and C‐terminal domains of HIV‐1 integrase protein and strongly inhibit HIV‐1 replication

C. Barbas, D. Harrich, R. Craigie, 2012, Biotechnology and applied biochemistry.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

D. Harrich, Ann Apolloni, M. Kershaw, 2013, Human gene therapy.